{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T18:23:54Z","timestamp":1790360634971,"version":"4.1.0"},"reference-count":58,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,7,1]],"date-time":"2012-07-01T00:00:00Z","timestamp":1341100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Prostaglandins, Leukotrienes and Essential Fatty Acids"],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1016\/j.plefa.2012.05.005","type":"journal-article","created":{"date-parts":[[2012,6,17]],"date-time":"2012-06-17T21:13:28Z","timestamp":1339967608000},"page":"35-41","source":"Crossref","is-referenced-by-count":34,"title":["Clinical and biochemical validation of two endophenotypes of schizophrenia defined by levels of polyunsaturated fatty acids in red blood cells"],"prefix":"10.1016","volume":"87","author":[{"given":"H.","family":"Bentsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.K.","family":"Solberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Refsum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"B\u00f8hmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.plefa.2012.05.005_bib1","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0920-9964(94)90043-4","article-title":"The membrane hypothesis of schizophrenia","volume":"13","author":"Horrobin","year":"1994","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.plefa.2012.05.005_bib2","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.conb.2009.05.001","article-title":"Redox dysregulation, neurodevelopment, and schizophrenia","volume":"19","author":"Do","year":"2009","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.plefa.2012.05.005_bib3","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.biopsych.2011.02.011","article-title":"Bimodal distribution of polyunsaturated fatty acids in schizophrenia suggests two endophenotypes of the disorder","volume":"70","author":"Bentsen","year":"2011","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.plefa.2012.05.005_bib4","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0920-9964(94)90084-1","article-title":"A red cell membrane abnormality in a subgroup of schizophrenic patients: evidence for two diseases","volume":"12","author":"Glen","year":"1994","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.plefa.2012.05.005_bib5","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0022-3956(95)00001-L","article-title":"Depleted red cell membrane essential fatty acids in drug-treated schizophrenic patients","volume":"29","author":"Peet","year":"1995","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.plefa.2012.05.005_bib6","unstructured":"S.R.Kay, Positive and negative syndromes in Schizophrenia. Assessment and Research, Brunner\/Mazel, New York, 1991."},{"key":"10.1016\/j.plefa.2012.05.005_bib7","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/(SICI)1234-988X(199612)6:4<227::AID-MPR162>3.3.CO;2-A","article-title":"The interrater reliability of the Positive and Negative Syndrome Scale (PANSS)","volume":"6","author":"Bentsen","year":"1996","journal-title":"Int. J. Meth. Psychiatr. Res."},{"key":"10.1016\/j.plefa.2012.05.005_bib8","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.comppsych.2006.03.008","article-title":"Generalizability studies of the Global Assessment of Functioning-Split version","volume":"48","author":"Pedersen","year":"2007","journal-title":"Compr. Psychiatry"},{"key":"10.1016\/j.plefa.2012.05.005_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-0447.1987.tb10566.x","article-title":"The UKU side effect rating scale. A new comprehensive rating scale for psychotropic drugs and a cross-sectional study of side effects in neuroleptic-treated patients","volume":"76","author":"Lingj\u00e6rde","year":"1987","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.plefa.2012.05.005_bib10","unstructured":"L.N.W.Daae, G.S.B.Lillesund, P.Urdal, [Medical laboratory investigations at the Oslo hospitals], Oslo Hospitals, Oslo,2000."},{"key":"10.1016\/j.plefa.2012.05.005_bib11","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0022-3956(98)90046-2","article-title":"Correlating and predicting psychiatric symptom ratings: Spearman's r versus Kendall's tau correlation","volume":"33","author":"Arndt","year":"1999","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.plefa.2012.05.005_bib12","series-title":"Applied Longitudinal Analysis","author":"Fitzmaurice","year":"2004"},{"key":"10.1016\/j.plefa.2012.05.005_bib13","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0895-4356(00)00314-0","article-title":"Adjusting for multiple testing\u2014when and how?","volume":"54","author":"Bender","year":"2001","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.plefa.2012.05.005_bib14","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1016\/S0140-6736(05)66461-6","article-title":"Multiplicity in randomised trials I: endpoints and treatments","volume":"365","author":"Schulz","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.plefa.2012.05.005_bib15","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1378\/chest.11-0523","article-title":"Correction for multiple testing: is there a resolution?","volume":"140","author":"Streiner","year":"2011","journal-title":"Chest"},{"key":"10.1016\/j.plefa.2012.05.005_bib16","first-page":"2537","article-title":"[Risk factors for myocardial infarction, stroke and diabetes in Norway]. [Norwegian]","volume":"127","author":"Graff-Iversen","year":"2007","journal-title":"Tidsskr. Nor. Laegeforen."},{"key":"10.1016\/j.plefa.2012.05.005_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0920-9964(98)00030-9","article-title":"Reduced status of plasma total antioxidant capacity in schizophrenia","volume":"32","author":"Yao","year":"1998","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.plefa.2012.05.005_bib18","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0165-1781(03)00222-1","article-title":"Overproduction of neutrophil radical oxygen species correlates with negative symptoms in schizophrenic patients: parallel studies on neutrophil chemotaxis, superoxide production and bactericidal activity","volume":"121","author":"Sirota","year":"2003","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.plefa.2012.05.005_bib19","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1093\/oxfordjournals.schbul.a007141","article-title":"Aggregability of red blood cells of schizophrenia patients with negative syndrome is selectively enhanced","volume":"30","author":"Barshtein","year":"2004","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.plefa.2012.05.005_bib20","doi-asserted-by":"crossref","first-page":"H2335","DOI":"10.1152\/ajpheart.01030.2002","article-title":"Changes of RBC aggregation in oxygenation-deoxygenation: pH dependency and cell morphology","volume":"284","author":"Cicha","year":"2003","journal-title":"Am. J. Physiol. Heart Cir. Physiol."},{"key":"10.1016\/j.plefa.2012.05.005_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.schres.2004.01.014","article-title":"The effects of antipsychotic therapy on serum lipids: a comprehensive review","volume":"70","author":"Meyer","year":"2004","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.plefa.2012.05.005_bib22","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.schres.2007.12.487","article-title":"Change in metabolic syndrome parameters with antipsychotic treatment in the CATIE Schizophrenia Trial: prospective data from phase 1","volume":"101","author":"Meyer","year":"2008","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.plefa.2012.05.005_bib23","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.plefa.2010.07.001","article-title":"Polyunsaturated fatty acids deficits are associated with psychotic state and negative symptoms in patients with schizophrenia","volume":"83","author":"Sethom","year":"2010","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"key":"10.1016\/j.plefa.2012.05.005_bib24","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1097\/01.nmd.0000131804.34977.c1","article-title":"Can patients at risk for persistent negative symptoms be identified during their first episode of psychosis?","volume":"192","author":"Malla","year":"2004","journal-title":"J. Nerv. Ment. Dis"},{"key":"10.1016\/j.plefa.2012.05.005_bib25","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0361-9230(01)00551-2","article-title":"The relationship between age and the fatty acid composition of cerebral cortex and erythrocytes in human subjects","volume":"56","author":"Carver","year":"2001","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.plefa.2012.05.005_bib26","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/S0006-3223(02)01397-5","article-title":"Correlations between peripheral polyunsaturated fatty acid content and in vivo membrane phospholipid metabolites","volume":"52","author":"Yao","year":"2002","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.plefa.2012.05.005_bib27","doi-asserted-by":"crossref","first-page":"10931","DOI":"10.1073\/pnas.0402342101","article-title":"Effects of dietary omega-3 polyunsaturated fatty acids on brain gene expression","volume":"101","author":"Kitajka","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.plefa.2012.05.005_bib28","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/nature04598","article-title":"Omega-3 and omega-6 fatty acids stimulate cell membrane expansion by acting on syntaxin 3","volume":"440","author":"Darios","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.plefa.2012.05.005_bib29","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1176\/appi.ajp.159.2.227","article-title":"A PET study of the pathophysiology of negative symptoms in schizophrenia. Positron emission tomography","volume":"159","author":"Potkin","year":"2002","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.plefa.2012.05.005_bib30","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1038\/sj.npp.1301628","article-title":"Ethyl-eicosapentaenoic acid in first-episode psychosis","volume":"33","author":"Berger","year":"2008","journal-title":"A 1H-MRS study, Neuropsychopharmacology"},{"key":"10.1016\/j.plefa.2012.05.005_bib31","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.schres.2009.12.030","article-title":"Subunit and whole molecule specificity of the anti-bovine casein immune response in recent onset psychosis and schizophrenia","volume":"118","author":"Severance","year":"2010","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.plefa.2012.05.005_bib32","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1161\/CIRCULATIONAHA.106.637793","article-title":"Triglycerides and the risk of coronary heart disease: 10,158 incident cases among 262,525 participants in 29 Western prospective studies","volume":"115","author":"Sarwar","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.plefa.2012.05.005_bib33","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3945\/ajcn.2008.26761","article-title":"Association of serum n-6 and n-3 polyunsaturated fatty acids with lipids in 3 populations of middle-aged men","volume":"90","author":"Motoyama","year":"2009","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.plefa.2012.05.005_bib34","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s11745-997-0056-6","article-title":"The effect of dietary arachidonic acid on plasma lipoprotein distributions, apoproteins, blood lipid levels, and tissue fatty acid composition in humans","volume":"32","author":"Nelson","year":"1997","journal-title":"Lipids"},{"key":"10.1016\/j.plefa.2012.05.005_bib35","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1161\/CIRCULATIONAHA.105.577296","article-title":"Dietary intake of n-6 fatty acids modulates effect of apolipoprotein A5 gene on plasma fasting triglycerides, remnant lipoprotein concentrations, and lipoprotein particle size: The Framingham Heart Study","volume":"113","author":"Lai","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.plefa.2012.05.005_bib36","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1093\/ajcn\/77.4.783","article-title":"Plant- and marine-derived n-3 polyunsaturated fatty acids have differential effects on fasting and postprandial blood lipid concentrations and on the susceptibility of LDL to oxidative modification in moderately hyperlipidemic subjects","volume":"77","author":"Finnegan","year":"2003","journal-title":"Am. J. Clin. Nutr"},{"key":"10.1016\/j.plefa.2012.05.005_bib37","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1093\/ajcn\/77.5.1146","article-title":"Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: a meta-analysis of 60 controlled trials","volume":"77","author":"Mensink","year":"2003","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.plefa.2012.05.005_bib38","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-1-4020-8831-5_1","article-title":"Transcriptional regulation of hepatic fatty acid metabolism","volume":"49","author":"Guillou","year":"2008","journal-title":"Subcell. Biochem"},{"key":"10.1016\/j.plefa.2012.05.005_bib39","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.cmet.2005.04.002","article-title":"New hepatic fat activates PPARalpha to maintain glucose, lipid, and cholesterol homeostasis","volume":"1","author":"Chakravarthy","year":"2005","journal-title":"Cell Metabolism"},{"key":"10.1016\/j.plefa.2012.05.005_bib40","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/sj.npp.1301142","article-title":"Atypical antipsychotic drugs directly impair insulin action in adipocytes: effects on glucose transport, lipogenesis, and antilipolysis","volume":"32","author":"Vestri","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.plefa.2012.05.005_bib41","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s00213-008-1370-x","article-title":"Acute clozapine exposure in vivo induces lipid accumulation and marked sequential changes in the expression of SREBP, PPAR, and LXR target genes in rat liver","volume":"203","author":"Ferno","year":"2009","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.plefa.2012.05.005_bib42","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1017\/S1461145708008468","article-title":"Increased expression of lipid biosynthesis genes in peripheral blood cells of olanzapine-treated patients","volume":"11","author":"Vik-Mo","year":"2008","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.plefa.2012.05.005_bib43","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1023\/A:1023429409048","article-title":"Typical changes of reversible erythrocyte aggregation in various pathological processes","volume":"135","author":"Ryazantseva","year":"2003","journal-title":"Bull. Exp. Biol. Med."},{"key":"10.1016\/j.plefa.2012.05.005_bib44","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/dmrr.502","article-title":"Association of components of the metabolic syndrome with the appearance of aggregated red blood cells in the peripheral blood. An unfavorable hemorheological finding","volume":"21","author":"Toker","year":"2005","journal-title":"Diabetes Metab. Res. Rev"},{"key":"10.1016\/j.plefa.2012.05.005_bib45","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1111\/j.1399-5618.2009.00757.x","article-title":"Similar immune profile in bipolar disorder and schizophrenia: selective increase in soluble tumor necrosis factor receptor I and von Willebrand factor","volume":"11","author":"Hope","year":"2009","journal-title":"Bipolar Disorders"},{"key":"10.1016\/j.plefa.2012.05.005_bib46","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1038\/nature08186","article-title":"Common variants conferring risk of schizophrenia","volume":"460","author":"Stefansson","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.plefa.2012.05.005_bib47","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/S0163-8343(99)00003-1","article-title":"Laboratory findings in acute schizophrenia. Relevance to medical management on emergency admission","volume":"21","author":"Hatta","year":"1999","journal-title":"Gen. Hosp. Psychiatry"},{"key":"10.1016\/j.plefa.2012.05.005_bib48","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1046\/j.1365-2362.1998.00323.x","article-title":"Regulation of iron metabolism in the acute-phase response: interferon gamma and tumour necrosis factor alpha induce hypoferraemia, ferritin production and a decrease in circulating transferrin receptors in cancer patients","volume":"28","author":"Feelders","year":"1998","journal-title":"Eur. J. Clin. Invest."},{"key":"10.1016\/j.plefa.2012.05.005_bib49","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.schres.2007.03.022","article-title":"C-reactive protein is associated with the severity of cognitive impairment but not of psychiatric symptoms in individuals with schizophrenia","volume":"93","author":"Dickerson","year":"2007","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.plefa.2012.05.005_bib50","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1054\/clnu.2001.0438","article-title":"The meaning of hypoalbuminaemia in clinical practice","volume":"20","author":"Franch-Arcas","year":"2001","journal-title":"Clin. Nutr."},{"key":"10.1016\/j.plefa.2012.05.005_bib51","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0920-9964(96)00037-0","article-title":"Acute phase proteins in male Chinese schizophrenic patients in Singapore","volume":"22","author":"Wong","year":"1996","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.plefa.2012.05.005_bib52","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0165-1781(00)00230-4","article-title":"Abnormal age-related changes of plasma antioxidant proteins in schizophrenia","volume":"97","author":"Yao","year":"2000","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.plefa.2012.05.005_bib53","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0920-9964(02)00407-3","article-title":"Reduced plasma antioxidants in first-episode patients with schizophrenia","volume":"62","author":"Reddy","year":"2003","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.plefa.2012.05.005_bib54","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1159\/000077942","article-title":"Decreased plasma antioxidants in schizophrenia","volume":"50","author":"Pae","year":"2004","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.plefa.2012.05.005_bib55","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/S0895-4356(97)00015-2","article-title":"Association of serum albumin and mortality risk","volume":"50","author":"Goldwasser","year":"1997","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.plefa.2012.05.005_bib56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000235706","article-title":"Evolutionary aspects of the dietary omega-6:omega-3 fatty acid ratio: medical implications","volume":"100","author":"Simopoulos","year":"2009","journal-title":"World Rev. Nutr. Dietetics"},{"key":"10.1016\/j.plefa.2012.05.005_bib57","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.plefa.2008.09.016","article-title":"The relationship between the fatty acid composition of immune cells and their function","volume":"79","author":"Calder","year":"2008","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"key":"10.1016\/j.plefa.2012.05.005_bib58","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1093\/schbul\/sbl057","article-title":"Persistent negative symptoms in schizophrenia: an overview","volume":"33","author":"Buchanan","year":"2007","journal-title":"Schizophr. Bull."}],"container-title":["Prostaglandins, Leukotrienes and Essential Fatty Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952327812000725?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952327812000725?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,30]],"date-time":"2019-06-30T01:26:03Z","timestamp":1561857963000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0952327812000725"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7]]},"references-count":58,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["S0952327812000725"],"URL":"https:\/\/doi.org\/10.1016\/j.plefa.2012.05.005","relation":{},"ISSN":["0952-3278"],"issn-type":[{"value":"0952-3278","type":"print"}],"subject":[],"published":{"date-parts":[[2012,7]]}}}